Expression and roles of MICA in human osteosarcoma

Histopathology

Volumn 52, Issue 5, 2008, Pages 640-642

  Xiao, P ^a   Xue, L ^a   Che, L H ^a   Peng, J J ^a   Wu, H X ^a   Li, Y ^a   Qiao, H ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL KILLER CELL RECEPTOR NKG2D; PROTEIN MICA; UNCLASSIFIED DRUG;

CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; LETTER; OSTEOSARCOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION;

BIOPSY; BONE NEOPLASMS; CELL COUNT; DISEASE PROGRESSION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; NEOPLASM STAGING; OSTEOSARCOMA; RECEPTORS, IMMUNOLOGIC; TUMOR MARKERS, BIOLOGICAL;

EID: 41149099940     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2008.02989.x     Document Type: Letter

References (5)

1. Bahram S. MIC genes: from genetics to biology. Adv. Immunol. 2000 76 1 60.
2. Jamieson AM, Diefenbach A, McMahon CW, Xiong N, Carlyle JR, Raulet DH. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity 2002 17 19 29.
3. Groh V, Rhinehart R, Secrist H et al. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc. Natl. Acad. Sci. U.S.A. 1999 96 6879 6884.
4. Groh V, Wu J, Yee C et al. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 2002 419 734 738.
5. Vetter CS, Groh V, Thor Straten P et al. Expression of stress-induced MHC class I related chain molecules on human melanoma. J. Invest. Dermatol. 2002 118 600 605.